IRIS
MESSINA, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.922
EU - Europa 6.058
AS - Asia 5.491
SA - Sud America 2.876
AF - Africa 179
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 23.561
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.725
BR - Brasile 2.538
SG - Singapore 2.222
IE - Irlanda 1.675
CN - Cina 1.535
SE - Svezia 1.003
HK - Hong Kong 703
IT - Italia 688
DE - Germania 613
PL - Polonia 467
VN - Vietnam 407
FI - Finlandia 366
UA - Ucraina 346
RU - Federazione Russa 303
GB - Regno Unito 234
FR - Francia 147
IN - India 139
AR - Argentina 129
MX - Messico 90
BD - Bangladesh 70
EC - Ecuador 64
CA - Canada 61
TR - Turchia 58
ID - Indonesia 52
ZA - Sudafrica 51
AT - Austria 45
IQ - Iraq 42
BE - Belgio 41
UZ - Uzbekistan 39
MA - Marocco 38
VE - Venezuela 35
NL - Olanda 31
JP - Giappone 28
PY - Paraguay 27
PK - Pakistan 26
CI - Costa d'Avorio 24
CO - Colombia 23
CL - Cile 20
ES - Italia 19
TN - Tunisia 18
CZ - Repubblica Ceca 17
IL - Israele 17
KE - Kenya 17
JO - Giordania 16
PE - Perù 16
UY - Uruguay 16
KZ - Kazakistan 15
AZ - Azerbaigian 14
NP - Nepal 14
EG - Egitto 12
IR - Iran 12
LT - Lituania 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 11
EU - Europa 11
PA - Panama 11
NZ - Nuova Zelanda 10
AU - Australia 8
LB - Libano 8
DZ - Algeria 7
OM - Oman 7
PS - Palestinian Territory 7
RS - Serbia 7
AL - Albania 6
BO - Bolivia 6
KW - Kuwait 6
DO - Repubblica Dominicana 5
HN - Honduras 5
JM - Giamaica 5
KR - Corea 5
LK - Sri Lanka 5
PH - Filippine 5
CY - Cipro 4
HR - Croazia 4
NI - Nicaragua 4
PT - Portogallo 4
QA - Qatar 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BG - Bulgaria 3
GE - Georgia 3
HU - Ungheria 3
SA - Arabia Saudita 3
SN - Senegal 3
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
GA - Gabon 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A1 - Anonimo 1
Totale 23.543
Salva come PNG Salva come JPEG
Città #
Dublin 1.669
Dallas 1.126
Chandler 1.064
Singapore 1.043
Ashburn 917
Jacksonville 793
Beijing 709
Hong Kong 703
Nyköping 571
Warsaw 455
Princeton 365
Medford 308
Cambridge 261
The Dalles 238
Los Angeles 227
Des Moines 215
Ann Arbor 212
Dearborn 182
Messina 181
São Paulo 164
Boardman 146
Buffalo 145
Ho Chi Minh City 137
Munich 126
San Mateo 94
Moscow 93
Lancaster 92
New York 90
Redondo Beach 88
Hanoi 76
Shenyang 75
Tianjin 74
Rio de Janeiro 72
Wilmington 72
Jinan 71
Pune 70
Bremen 68
Turku 64
Rome 61
Belo Horizonte 56
Nanjing 53
Brasília 52
Houston 47
Porto Alegre 44
Woodbridge 44
Curitiba 43
Brussels 38
Dong Ket 38
Tashkent 37
Hangzhou 35
Zhengzhou 35
Campinas 33
Ningbo 33
Hebei 32
Nuremberg 32
Brooklyn 31
Guarulhos 29
Tokyo 26
Helsinki 25
Abidjan 24
Frankfurt am Main 24
Johannesburg 24
Ribeirão Preto 24
Vienna 24
Haikou 23
Seattle 23
Atlanta 22
Guayaquil 22
Jakarta 22
Taizhou 22
Baghdad 21
Lappeenranta 21
Quito 21
Stockholm 21
Mexico City 20
Nanchang 20
Salvador 20
Sorocaba 20
São José do Rio Preto 20
Juiz de Fora 19
Norwalk 19
Catania 18
Fortaleza 18
Goiânia 18
Guangzhou 18
Joinville 18
Toronto 18
Nürnberg 17
Osasco 17
San Francisco 17
Santa Clara 17
Asunción 16
Biên Hòa 16
Chennai 16
Contagem 16
Santo André 16
Boston 15
Changsha 15
Falls Church 15
London 15
Totale 14.672
Salva come PNG Salva come JPEG
Nome #
Severe rhabdomyolysis in a patient with “Heat Stroke” 236
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 177
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 159
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 152
Hippo signaling pathway is altered in Duchenne muscular dystrophy 142
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 139
A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features 138
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 138
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 137
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 129
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 129
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 126
Alexithymia, burden and resilience in ALS’ caregivers 126
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 126
Autonomic nervous system involvement in spinal muscular atrophy. 123
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 119
ANT1 is reduced in sporadic inclusion body myositis. 119
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 117
Nusinersen versus sham control in later-onset spinal muscular atrophy 117
Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. 115
Effect of exercise on telomere length and telomere proteins expression in mdx mice 115
The 24-month PUL changes and steroids correlation. 114
An observational study of functional abilities in infants, children, and adults with type 1 SMA 114
Pilot study of serial casting in muscular dystrophy patients. 112
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 112
Apoptosis and apoptosis-related proteins in thyroid myopathies 111
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 111
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 111
Pilot study of flavocoxid in ambulant DMD patients. 110
Pilot study of serial casting of ankles in muscular dystrophy patients. 110
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 108
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 108
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 108
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 107
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 106
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 105
Histological effects of givinostat in boys with Duchenne muscular dystrophy 104
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 104
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 104
The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. 103
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 103
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 103
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 103
Pilot study of flavocoxid in ambulant DMD patients. 102
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 102
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 102
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 102
A comprehensive molecular approach in COLA6 related myopathies based on genomic sequencing, transcriptional analysis and array CGH. 101
24-Holter ECG in type II and III SMA 101
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 101
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 101
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 101
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 100
Severe rhabdomyolysis in a patient with “Heat Stroke” 99
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 99
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 99
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 98
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data 98
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 97
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 97
Genomic Variations Affecting Biological Effects of Statins 97
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 97
Development of an academic disease registry for spinal muscular atrophy 96
Age and baseline values predict 12 and 24-month functional changes in type 2 SMA 96
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 95
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 95
Pilot study of flavocoxid in ambulant DMD patients. 95
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 94
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 94
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 94
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 93
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 93
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 93
Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis 93
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 93
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 92
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 92
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 92
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 92
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 91
Conceptualizing the relations between metacognition and executive functions in Amyotrophic Lateral Sclerosis (ALS) patients’ caregivers. A preliminary study 91
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 90
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 90
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 89
Clinical variability in spinal muscular atrophy type III 89
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 88
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 88
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 87
Bone quality in Duchenne muscular dystrophy 87
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies in the UK and differences with the Italian population 86
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 86
Seizure aggravation caused by antiepileptic drugs in a patient with muscle-eye-brain disease. 85
study of flavocoxid in ambulant DMD patients. 85
6 min walking test 12 month changes in DMD: Correlation with genotype. 85
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 84
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 84
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 83
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 82
EFFECT OF TREATMENT WITH PDTC AND IRFI 042 ON STRENGTH AND FATIGUE IN MDX MICE 82
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 82
Totale 10.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021833 0 0 0 0 0 128 91 165 53 200 106 90
2021/20221.696 9 123 13 113 97 14 126 72 51 119 211 748
2022/20234.412 392 321 161 311 381 388 29 237 2.010 21 122 39
2023/20241.118 84 202 73 101 115 216 48 31 16 43 28 161
2024/20255.751 98 76 102 352 246 151 162 1.370 1.514 330 432 918
2025/20265.870 698 1.202 1.311 1.304 1.190 165 0 0 0 0 0 0
Totale 24.159